Stay updated on Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No visible changes to the study details or page layout.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2 with no changes to study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 removed, a minor site update that does not affect study content or user tasks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedUI updates include showing a glossary and refinements to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' plus a new footer revision 'Revision: v3.4.0' replacing the old 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page's revision history.SummaryDifference0.0%

- Check83 days agoChange DetectedLocations for several German states were added (Baden-Wurttemberg, Bavaria, Hesse, North Rhine-Westphalia, Rhineland-Palatinate, Saxony-Anhalt, State of Berlin) and corresponding blocks removed; the revision shows as v3.3.3.SummaryDifference0.8%

Stay in the know with updates to Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.